Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trialAndrew D. Zelenetz, Franck Morschhauser, Martine E.D. Chamuleau et al.|Blood|2019Cited by 136
Prognostic Impact of Cell of Origin in Limited-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP With or Without Radiation TherapyPaul Youn, Louis S. Constine, Michael Cummings et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 1
The Role of Radiation Therapy in Patients with Stage III Classical Hodgkin Lymphoma: A Propensity Score Matched Analysis of the Surveillance, Epidemiology, and End Results DatabaseJames E. Bates, Louis S. Constine, S. Dhakal et al.|International Journal of Radiation Oncology*Biology*Physics|2017Cited by 0
Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma: Results of a multicenter phase II trialReid W. Merryman, Yazeed Sawalha, Danielle Wallace et al.|Blood|2025Cited by 0